Respiratory Syncytial Virus (RSV) infection in adults has emerged as a significant health concern, leading
RSV vaccination effectiveness has become a pivotal focus in combating respiratory syncytial virus (RSV) among
In the realm of public health, the cost-effectiveness of RSV vaccination is becoming an increasingly
Respiratory syncytial virus (RSV) hospitalization rates have become a critical concern as recent studies reveal
Beyfortus, a groundbreaking long-acting monoclonal antibody, is making headlines following the recent announcement from the